Kymriah Interactions
There are 169 drugs known to interact with Kymriah (tisagenlecleucel), along with 5 disease interactions. Of the total drug interactions, 49 are major, and 120 are moderate.
- View all 169 medications that may interact with Kymriah
- View Kymriah disease interactions (5)
Most frequently checked interactions
View interaction reports for Kymriah (tisagenlecleucel) and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- acetaminophen
- Actemra (tocilizumab)
- Adalat CC (nifedipine)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Afinitor (everolimus)
- aldesleukin
- Alprolix (coagulation factor ix)
- Ambien (zolpidem)
- Ambien CR (zolpidem)
- Amevive (alefacept)
- Amicar (aminocaproic acid)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Cosentyx (secukinumab)
- Crysvita (burosumab)
- Gleevec (imatinib)
- Idelvion (coagulation factor ix)
- Intelence (etravirine)
- Isentress (raltegravir)
- Jadenu (deferasirox)
- Jakafi (ruxolitinib)
- metformin
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Pulmozyme (dornase alfa)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- tramadol
- Trecator-SC (ethionamide)
- Yescarta (axicabtagene ciloleucel)
Kymriah disease interactions
There are 5 disease interactions with Kymriah (tisagenlecleucel) which include:
Report options
QR code containing a link to this page
More about Kymriah (tisagenlecleucel)
- Kymriah consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
